Aura Biosciences, Inc.
AURA
$7.93
-$0.26-3.18%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -25.56M | -26.13M | -27.02M | -27.48M | -25.83M |
| Total Depreciation and Amortization | 272.00K | 280.00K | 286.00K | 291.00K | 291.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.26M | 3.74M | 3.93M | 3.41M | 2.53M |
| Change in Net Operating Assets | 1.56M | 1.96M | 2.03M | 423.00K | -942.00K |
| Cash from Operations | -20.47M | -20.14M | -20.77M | -23.36M | -23.95M |
| Capital Expenditure | -176.00K | -45.00K | -39.00K | -187.00K | -299.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 30.00M | -43.97M | 20.02M | 30.00M | 29.99M |
| Cash from Investing | 29.82M | -44.02M | 19.98M | 29.81M | 29.70M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.77M | 4.36M | 46.52M | 96.00K | 543.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 23.41M | -- | -- |
| Cash from Financing | 2.77M | 4.36M | 69.93M | 96.00K | 543.00K |
| Foreign Exchange rate Adjustments | -160.00K | -14.00K | 9.00K | -21.00K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 11.96M | -59.81M | 69.14M | 6.53M | 6.29M |